Cargando…
Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage
The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265186/ https://www.ncbi.nlm.nih.gov/pubmed/34258235 http://dx.doi.org/10.1016/j.toxrep.2021.07.004 |
_version_ | 1783719719286603776 |
---|---|
author | Chalkias, Athanasios Pantazopoulos, Ioannis Papagiannakis, Nikolaos Skoulakis, Anargyros Laou, Eleni Kolonia, Konstantina Ntalarizou, Nicoletta Tourlakopoulos, Konstantinos Pagonis, Athanasios Kampolis, Christos De Guadiana Romualdo, Luis García Ragias, Dimitrios Eugen-Olsen, Jesper Gourgoulianis, Konstantinos Arnaoutoglou, Eleni |
author_facet | Chalkias, Athanasios Pantazopoulos, Ioannis Papagiannakis, Nikolaos Skoulakis, Anargyros Laou, Eleni Kolonia, Konstantina Ntalarizou, Nicoletta Tourlakopoulos, Konstantinos Pagonis, Athanasios Kampolis, Christos De Guadiana Romualdo, Luis García Ragias, Dimitrios Eugen-Olsen, Jesper Gourgoulianis, Konstantinos Arnaoutoglou, Eleni |
author_sort | Chalkias, Athanasios |
collection | PubMed |
description | The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion criteria were: (a) adult (≥18 years old) patients hospitalized primarily for COVID-19; (b) a confirmed SARS-CoV-2 infection diagnosed through reverse transcriptase polymerase chain reaction test of nasopharyngeal or oropharyngeal samples; and (c) at least one blood sample collected at admission and stored for suPAR, hs-CRP, and ferritin testing. All patients had continuous heart rate monitoring during hospitalization. In total, 81 patients were included. Of them, 17 (21 %) and 64 (79 %) were intubated and admitted to the ICU during the first and second wave, respectively. Two (12 %) and 62 (97 %) developed bradycardia before ICU admission, respectively (p < 0.001). Patients with bradycardia had increased suPAR (p < 0.001) and hs-CRP level (p < 0.001). Infusion of isoprenaline and/or noradrenaline was necessary to maintain an adequate rate and peripheral perfusion in all patients. Mortality was significantly higher in patients with bradycardia (p < 0.001). In conclusion, bradycardia was associated with poor outcome. As B.1.1.7 variant strain is spreading more rapidly in many countries, our findings help in the identification of patients who may require early admission to ICU. |
format | Online Article Text |
id | pubmed-8265186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82651862021-07-09 Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage Chalkias, Athanasios Pantazopoulos, Ioannis Papagiannakis, Nikolaos Skoulakis, Anargyros Laou, Eleni Kolonia, Konstantina Ntalarizou, Nicoletta Tourlakopoulos, Konstantinos Pagonis, Athanasios Kampolis, Christos De Guadiana Romualdo, Luis García Ragias, Dimitrios Eugen-Olsen, Jesper Gourgoulianis, Konstantinos Arnaoutoglou, Eleni Toxicol Rep Regular Article The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion criteria were: (a) adult (≥18 years old) patients hospitalized primarily for COVID-19; (b) a confirmed SARS-CoV-2 infection diagnosed through reverse transcriptase polymerase chain reaction test of nasopharyngeal or oropharyngeal samples; and (c) at least one blood sample collected at admission and stored for suPAR, hs-CRP, and ferritin testing. All patients had continuous heart rate monitoring during hospitalization. In total, 81 patients were included. Of them, 17 (21 %) and 64 (79 %) were intubated and admitted to the ICU during the first and second wave, respectively. Two (12 %) and 62 (97 %) developed bradycardia before ICU admission, respectively (p < 0.001). Patients with bradycardia had increased suPAR (p < 0.001) and hs-CRP level (p < 0.001). Infusion of isoprenaline and/or noradrenaline was necessary to maintain an adequate rate and peripheral perfusion in all patients. Mortality was significantly higher in patients with bradycardia (p < 0.001). In conclusion, bradycardia was associated with poor outcome. As B.1.1.7 variant strain is spreading more rapidly in many countries, our findings help in the identification of patients who may require early admission to ICU. Elsevier 2021-07-08 /pmc/articles/PMC8265186/ /pubmed/34258235 http://dx.doi.org/10.1016/j.toxrep.2021.07.004 Text en © 2021 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular Article Chalkias, Athanasios Pantazopoulos, Ioannis Papagiannakis, Nikolaos Skoulakis, Anargyros Laou, Eleni Kolonia, Konstantina Ntalarizou, Nicoletta Tourlakopoulos, Konstantinos Pagonis, Athanasios Kampolis, Christos De Guadiana Romualdo, Luis García Ragias, Dimitrios Eugen-Olsen, Jesper Gourgoulianis, Konstantinos Arnaoutoglou, Eleni Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage |
title | Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage |
title_full | Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage |
title_fullStr | Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage |
title_full_unstemmed | Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage |
title_short | Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage |
title_sort | sinus bradycardia is associated with poor outcome in critically ill patients with covid-19 due to the b.1.1.7 lineage |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265186/ https://www.ncbi.nlm.nih.gov/pubmed/34258235 http://dx.doi.org/10.1016/j.toxrep.2021.07.004 |
work_keys_str_mv | AT chalkiasathanasios sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT pantazopoulosioannis sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT papagiannakisnikolaos sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT skoulakisanargyros sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT laoueleni sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT koloniakonstantina sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT ntalarizounicoletta sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT tourlakopouloskonstantinos sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT pagonisathanasios sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT kampolischristos sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT deguadianaromualdoluisgarcia sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT ragiasdimitrios sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT eugenolsenjesper sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT gourgoulianiskonstantinos sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT arnaoutogloueleni sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage AT sinusbradycardiaisassociatedwithpooroutcomeincriticallyillpatientswithcovid19duetotheb117lineage |